Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

(2019) Oliver Preische et al.   NATURE MEDICINE

Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study

(2019) Jessica L. Panman et al.   NEUROBIOLOGY OF AGING

An update on genetic frontotemporal dementia

(2019) Caroline V. Greaves et al.   JOURNAL OF NEUROLOGY

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

(2019) Adam M. Staffaroni et al.   Alzheimers & Dementia

Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers

(2019) Qin Chen et al.   JOURNAL OF NEUROIMAGING

A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers

(2019) Rogier A Feis et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers

(2019) Qin Chen et al.   NEUROLOGY

Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis

(2019) Yinan Zhao et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers

(2019) Qin Chen et al.   NEUROBIOLOGY OF AGING

Slowly progressive behavioral frontotemporal dementia with C9orf72 mutation. Case report and review of the literature

(2018) S. Llamas-Velasco et al.   NEUROCASE

Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers

(2018) Christopher A. Olm et al.   NeuroImage-Clinical

How early can we diagnose Alzheimer disease (and is it sufficient)?

(2018) Ronald C. Petersen   NEUROLOGY

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory

(2018) Peter A. Ljubenkov et al.   Annals of Clinical and Translational Neurology

Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia

(2018) Lize C Jiskoot et al.   BRAIN

Multimodal imaging in familial FTLD: phenoconversion and planning for the future

(2018) Bradley F Boeve et al.   BRAIN

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease

(2018) Ann D. Cohen et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials

(2018) Adam M Staffaroni et al.   BRAIN

The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

(2017) Zahinoor Ismail et al.   JOURNAL OF ALZHEIMERS DISEASE

Longitudinal diffusion imaging across theC9orf72clinical spectrum

(2017) Mary Kay Floeter et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Alzheimer's Disease–Related Dementias Summit 2016: National research priorities

(2017) Roderick A. Corriveau et al.   NEUROLOGY

The social and economic burden of frontotemporal degeneration

(2017) James E. Galvin et al.   NEUROLOGY

Randomized controlled trials in mild cognitive impairment

(2017) Ronald C. Petersen et al.   NEUROLOGY

Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy

(2017) Kiran Yanamandra et al.   Science Translational Medicine

Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration

(2017) Richard J. Binney et al.   Brain and Behavior

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers

(2017) Suzee E. Lee et al.   NeuroImage-Clinical

Therapy and clinical trials in frontotemporal dementia: past, present, and future

(2016) Richard M. Tsai et al.   JOURNAL OF NEUROCHEMISTRY

Presymptomatic cognitive decline in familial frontotemporal dementia

(2016) Lize C. Jiskoot et al.   NEUROLOGY

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

(2016) Ian T.S. Coyle-Gilchrist et al.   NEUROLOGY

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study

(2016) Elise G.P. Dopper et al.   NeuroImage-Clinical

Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype

(2016) Mary Kay Floeter et al.   NeuroImage-Clinical

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

(2016) Julio C. Rojas et al.   Annals of Clinical and Translational Neurology

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

(2016) Lieke H. Meeter et al.   Annals of Clinical and Translational Neurology

Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images

(2015) J. L. Whitwell et al.   EUROPEAN JOURNAL OF NEUROLOGY

Frontotemporal dementia

(2015) Jee Bang et al.   LANCET

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

(2015) Jonathan D Rohrer et al.   LANCET NEUROLOGY

Longitudinal diffusion tensor imaging in frontotemporal dementia

(2014) Colin J. Mahoney et al.   ANNALS OF NEUROLOGY

Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases

(2014) Giulietta Riboldi et al.   MOLECULAR NEUROBIOLOGY

Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia

(2014) E. G. P. Dopper et al.   NEUROLOGY

Recommendations of the Alzheimer's Disease-Related Dementias Conference

(2014) T. J. Montine et al.   NEUROLOGY

Oxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability

(2014) E. C. Finger et al.   NEUROLOGY

The A4 Study: Stopping AD Before Symptoms Begin?

(2014) R. A. Sperling et al.   Science Translational Medicine

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

(2013) Carole S. Scherling et al.   ANNALS OF NEUROLOGY

Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial

(2013) Adam L Boxer et al.   LANCET NEUROLOGY

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers

(2013) C. Jacova et al.   NEUROLOGY

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial

(2013) S.M. Mills et al.   REVUE NEUROLOGIQUE

Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development

(2012) Adam L. Boxer et al.   Alzheimers & Dementia

Atypical, slowly progressive behavioural variant frontotemporal dementia associated withC9ORF72hexanucleotide expansion

(2012) Baber K Khan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Advances in understanding the molecular basis of frontotemporal dementia

(2012) Rosa Rademakers et al.   Nature Reviews Neurology

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

(2012) J.- M. Lee et al.   NEUROLOGY

Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions

(2012) Colin J Mahoney et al.   Alzheimers Research & Therapy

Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN

(2011) J. L. Whitwell et al.   NEUROLOGY

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

(2011) Mariely DeJesus-Hernandez et al.   NEURON

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

(2011) Alan E. Renton et al.   NEURON

Frequency and Causes of Early-onset Dementia in a Tertiary Referral Center in Athens

(2010) Sokratis G. Papageorgiou et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Longitudinal Rates of Lobar Atrophy in Frontotemporal Dementia, Semantic Dementia, and Alzheimerʼs Disease

(2010) Casey E. Krueger et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis

(2010) Jennifer Merrilees et al.   Amyotrophic Lateral Sclerosis

Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study

(2010) E. Gordon et al.   NEUROLOGY

The heritability and genetics of frontotemporal lobar degeneration

(2009) J. D. Rohrer et al.   NEUROLOGY

Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year

(2009) D. S. Knopman et al.   NEUROLOGY

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

(2008) D. S. Knopman et al.   BRAIN

Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease

(2007) Jennifer L. Whitwell et al.   NEUROIMAGE